Oxymorphone - Endo Pharmaceuticals
Alternative Names: EN 3202; EN 3203; Opana; Opana ER; oxymorphone HClLatest Information Update: 08 Jan 2022
At a glance
- Originator Endo Pharmaceuticals
- Class Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Musculoskeletal pain
- Phase III Postoperative pain
- Market Withdrawal Cancer pain